Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia

Severe congenital neutropenia (SCN) is characterized by chronic neutropenia with recurrent infections from early infancy and a predisposition to myelodysplastic syndrome/acute myeloid leukemia (AML). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patient...

Full description

Bibliographic Details
Main Authors: Risa Matsumura, Shinji Mochizuki, Yusuke Morishita, Hiroko Hayakawa, Shuhei Karakawa, Hiroshi Kawaguchi, Satoshi Okada, Nobuyuki Hyakuna, Masao Kobayashi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Hematology Reports
Subjects:
Online Access:https://www.mdpi.com/2038-8330/16/1/10
_version_ 1827306128494559232
author Risa Matsumura
Shinji Mochizuki
Yusuke Morishita
Hiroko Hayakawa
Shuhei Karakawa
Hiroshi Kawaguchi
Satoshi Okada
Nobuyuki Hyakuna
Masao Kobayashi
author_facet Risa Matsumura
Shinji Mochizuki
Yusuke Morishita
Hiroko Hayakawa
Shuhei Karakawa
Hiroshi Kawaguchi
Satoshi Okada
Nobuyuki Hyakuna
Masao Kobayashi
author_sort Risa Matsumura
collection DOAJ
description Severe congenital neutropenia (SCN) is characterized by chronic neutropenia with recurrent infections from early infancy and a predisposition to myelodysplastic syndrome/acute myeloid leukemia (AML). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with SCN who develop myelodysplastic syndrome/AML. We report an 8-year-old girl with SCN carrying an <i>ELANE</i> mutation that had been refractory to granulocyte colony-stimulating factor. The patient experienced recurrent infections and then developed AML. The counts of leukemic blasts that harbored both <i>CSF3R</i> and <i>RUNX1</i> mutations spontaneously decreased with antimicrobial therapy, leading to partial remission. After AML recurrence, HSCT was successfully performed using modified chemotherapy and a conditioning regimen. Serial donor lymphocyte infusions against mixed chimerism induced complete donor chimerism over 4 years without any infections or AML relapse. This case suggests the importance of carefully managing neutropenia-related infections, leukemia progression, and HSCT in patients with SCN developing AML.
first_indexed 2024-04-24T18:13:56Z
format Article
id doaj.art-cc4d307e65b14e40a5852c64eadf6211
institution Directory Open Access Journal
issn 2038-8330
language English
last_indexed 2024-04-24T18:13:56Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-cc4d307e65b14e40a5852c64eadf62112024-03-27T13:43:59ZengMDPI AGHematology Reports2038-83302024-02-011619810510.3390/hematolrep16010010Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for LeukemiaRisa Matsumura0Shinji Mochizuki1Yusuke Morishita2Hiroko Hayakawa3Shuhei Karakawa4Hiroshi Kawaguchi5Satoshi Okada6Nobuyuki Hyakuna7Masao Kobayashi8Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanDepartment of Pediatrics, University of the Ryukyus Hospital, Okinawa 903-0215, JapanDepartment of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, JapanSevere congenital neutropenia (SCN) is characterized by chronic neutropenia with recurrent infections from early infancy and a predisposition to myelodysplastic syndrome/acute myeloid leukemia (AML). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with SCN who develop myelodysplastic syndrome/AML. We report an 8-year-old girl with SCN carrying an <i>ELANE</i> mutation that had been refractory to granulocyte colony-stimulating factor. The patient experienced recurrent infections and then developed AML. The counts of leukemic blasts that harbored both <i>CSF3R</i> and <i>RUNX1</i> mutations spontaneously decreased with antimicrobial therapy, leading to partial remission. After AML recurrence, HSCT was successfully performed using modified chemotherapy and a conditioning regimen. Serial donor lymphocyte infusions against mixed chimerism induced complete donor chimerism over 4 years without any infections or AML relapse. This case suggests the importance of carefully managing neutropenia-related infections, leukemia progression, and HSCT in patients with SCN developing AML.https://www.mdpi.com/2038-8330/16/1/10severe congenital neutropeniaacute myeloid leukemiahematopoietic stem cell transplantation
spellingShingle Risa Matsumura
Shinji Mochizuki
Yusuke Morishita
Hiroko Hayakawa
Shuhei Karakawa
Hiroshi Kawaguchi
Satoshi Okada
Nobuyuki Hyakuna
Masao Kobayashi
Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
Hematology Reports
severe congenital neutropenia
acute myeloid leukemia
hematopoietic stem cell transplantation
title Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
title_full Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
title_fullStr Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
title_full_unstemmed Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
title_short Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
title_sort successful bone marrow transplantation in a patient with acute myeloid leukemia developed from severe congenital neutropenia using modified chemotherapy and conditioning regimen for leukemia
topic severe congenital neutropenia
acute myeloid leukemia
hematopoietic stem cell transplantation
url https://www.mdpi.com/2038-8330/16/1/10
work_keys_str_mv AT risamatsumura successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT shinjimochizuki successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT yusukemorishita successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT hirokohayakawa successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT shuheikarakawa successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT hiroshikawaguchi successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT satoshiokada successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT nobuyukihyakuna successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia
AT masaokobayashi successfulbonemarrowtransplantationinapatientwithacutemyeloidleukemiadevelopedfromseverecongenitalneutropeniausingmodifiedchemotherapyandconditioningregimenforleukemia